Summary The relation between the use of combination oral contraceptives (OCs) and the risk of epithelial ovarian cancer was investigated in a case-control study conducted in Milan on 209 women below the age of 60 with histologically confirmed epithelial ovarian cancer, and 418 age-matched controls with a spectrum of acute conditions apparently unrelated to OC use. Combination oral contraceptives were used by 18 (9%) cases, and 59 (14%) controls, giving a relative risk estimate of 0.6 (95% confidence interval=0.3-1.0, P<0.05). The risk of ovarian cancer decreased with increasing duration of use and the point estimate remained below unity long after cessation of use. These results were not accounted for by parity, infertility, or other identified potential confounding factors. Thus, the findings of the present study add further support to the evidence emerging from American data of a reduction of -40% in the risk of epithelial ovarian cancer among women who had used oral contraceptives.Evidence from several case-control studies conducted mainly in North America (McGowan et al., 1979;Annegers et al., 1979;Hildreth et al., 1981;Weiss et al., 1981;Willett et al., 1981;Rosenberg et al., 1982;Cramer et al., 1982;Casagrande et al., 1983; Centers for Disease Control Cancer and Steroid Hormone Study, 1983; see also Newhouse et al., 1977) suggests that the use of cQmbined oral contraceptives (OCs) reduces the risk of epthelial ovarian cancer. General lifestyle and reproductive characteristics, however, are notoriously different in Italy. Oral contraceptive use, in particular, is less common and usually concentrated in the younger age groups. It is, therefore, of interest to re-evaluate the relation of OC use to the risk of ovarian cancer in such a population. This has been done in the present study, using data from a case-control study conducted in Milan.
Subjects and methodsSince 1979, we have conducted a case-control study of ovarian cancer (Franceschi et al., 1982). Trained interviewers identify and question women admitted for ovarian cancer and for a wide spectrum of other conditions to University and General Hospitals in the Greater Milan area. On the average, <2% of the eligible women (cases or controls) refuse to be interviewed.A standard questionnaire is used to obtain information on personal characteristics and habits, gynaecological and obstetric data, related medical history and history of lifetime use of oral contraceptives and other female hormones. The present study is based on data obtained before September 30, 1983.
CasesThe cases studied were women with histologically confirmed epithelial ovarian cancer, diagnosed within the year prior to interview, admitted to the First Obstetrics and Gynaecology Clinic of the University and to the National Cancer Institute of Milan. There were 209 women younger than 60 years who met these criteria. The histological type was serous carcinoma in 61%, endometrioid carcinoma in 13%, mucinous carcinoma in 13%, clear cell carcinoma in 6%, and undifferentiated carcinoma in 7%....